Literature DB >> 15072459

Neuro-oncology in a nutshell.

Joachim M Baehring1.   

Abstract

Mesh：

Substances：

Year:  2004        PMID： 15072459     DOI： 10.1023/b:neon.0000022016.38833.54

Source DB:  PubMed          Journal:  J Neurooncol        ISSN： 0167-594X            Impact factor:   4.130


× No keyword cloud information.
  11 in total

Review 1.  Mechanisms of disease: the blood-brain barrier.

Authors:  Edward A Neuwelt
Journal:  Neurosurgery       Date:  2004-01       Impact factor: 4.654

Review 2.  Paraneoplastic neurological degenerations: keys to tumour immunity.

Authors:  Matthew L Albert; Robert B Darnell
Journal:  Nat Rev Cancer       Date:  2004-01       Impact factor: 60.716

3.  Detection of perineural spread: fat suppression versus no fat suppression.

Authors:  Hugh D Curtin
Journal:  AJNR Am J Neuroradiol       Date:  2004-01       Impact factor: 3.825

4.  Synergy between celecoxib and radiotherapy results from inhibition of cyclooxygenase-2-derived prostaglandin E2, a survival factor for tumor and associated vasculature.

Authors:  Thomas W Davis; Janet M O'Neal; Mark D Pagel; Ben S Zweifel; Pramod P Mehta; Deborah M Heuvelman; Jaime L Masferrer
Journal:  Cancer Res       Date:  2004-01-01       Impact factor: 12.701

5.  Enhanced radiation-induced cell killing and prolongation of gammaH2AX foci expression by the histone deacetylase inhibitor MS-275.

Authors:  Kevin Camphausen; William Burgan; Michael Cerra; Kelli A Oswald; Jane B Trepel; Min-Jung Lee; Philip J Tofilon
Journal:  Cancer Res       Date:  2004-01-01       Impact factor: 12.701

6.  Perineural spread of malignant melanoma of the head and neck: clinical and imaging features.

Authors:  Patrick C Chang; Nancy J Fischbein; Timothy H McCalmont; Mohammed Kashani-Sabet; Elizabeth M Zettersten; Amon Y Liu; Jane L Weissman
Journal:  AJNR Am J Neuroradiol       Date:  2004-01       Impact factor: 3.825

7.  Phase II trial of gefitinib in recurrent glioblastoma.

Authors:  Jeremy N Rich; David A Reardon; Terry Peery; Jeannette M Dowell; Jennifer A Quinn; Kara L Penne; Carol J Wikstrand; Lauren B Van Duyn; Janet E Dancey; Roger E McLendon; James C Kao; Timothy T Stenzel; B K Ahmed Rasheed; Sandra E Tourt-Uhlig; James E Herndon; James J Vredenburgh; John H Sampson; Allan H Friedman; Darell D Bigner; Henry S Friedman
Journal:  J Clin Oncol       Date:  2003-11-24       Impact factor: 44.544

8.  Stereotaxic implantation of 5-fluorouracil-releasing microspheres in malignant glioma.

Authors:  Philippe Menei; Eric Jadaud; Nathalie Faisant; Michèle Boisdron-Celle; Sophie Michalak; Dominique Fournier; Manuel Delhaye; Jean-Pierre Benoit
Journal:  Cancer       Date:  2004-01-15       Impact factor: 6.860

9.  Increased invasive capacity of connexin43-overexpressing malignant glioma cells.

Authors:  Wei Zhang; Chiedozie Nwagwu; Duc Minh Le; V Wee Yong; Hua Song; William T Couldwell
Journal:  J Neurosurg       Date:  2003-12       Impact factor: 5.115

10.  Combination of boron neutron capture therapy and external beam radiotherapy for brain tumors.

Authors:  Rolf F Barth; John C Grecula; Weilan Yang; Joan H Rotaru; Marta Nawrocky; Nilendu Gupta; Brent J Albertson; Amy K Ferketich; Melvin L Moeschberger; Jeffrey A Coderre; Einar K Rofstad
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-01-01       Impact factor: 7.038
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.